Search
User Profile
Change
Select your user profile

Heart Failure

Improving heart failure outcomes together at every step

As the leader in in vitro diagnostics (IVD), we discover and develop novel, high-quality, accurate assays for heart failure diagnostics, through:

  • Continuous innovation: Roche pioneered N-terminal pro-BNP (NT-proBNP) and has continued to invest in exploring the clinical utility of this biomarker, resulting in claim extensions that make it the NT-proBNP assay with the highest number of intended uses vs. main IVD providers1-9

  • Connecting solutions: At Roche, we are fully committed to supporting the optimal implementation of the biomarkers you need, with innovative solutions to assist healthcare professionals (HCPs) in improving outcomes

  • Co-creating evidence: We are proud to offer the most extensively validated NT-proBNP assay, giving you a cost-effective way to provide information to assist in clinical decision-making and treatment modification10-12

Do you have any questions?

Contact Us

Key Areas

  1. European Patent Office. EP 1 151 304 B1 patent document. Data on file.

  2. Roche. The NT-proBNP story. [Internet; cited 2024 July 17]. Available from: https://www.roche.com/stories/partnering-nt-probnp 

  3. Fischer Y, et al. Evaluation of a New, Rapid Bedside Test for Quantitative Determination of B-Type Natriuretic Peptide. Clinical Chemistry. 2001;47:591-4.

  4. Roche Elecsys® NT-proBNP v2.1 method sheet. 2023-05, V 2.1.

  5. Roche CARDIAC proBNP+ method sheet. 2023-06, V 1.0.

  6. Abbott. Alere NT-proBNP method sheet. 2018-05, V1.0.

  7. Beckman Coulter. Access NT-proBNP method sheet. C99356 F. 2023-04, V 10.0.

  8. Siemens Healthineers. Atellica® NT‑proBNP method sheet. 2022-10, V 5.0.

  9. Biolabs Diagnostics. MagIumi NT-proBNP method sheet. V 3.0.

  10. Walkley R, et al. The cost-effectiveness of NT-proBNP for assessment of suspected acute heart failure in the emergency department. ESC Heart Fail. 2023;10:3276-3286.

  11. Walter E, et al. Cost-effectiveness of NT-proBNP-supported screening of chronic heart failure in patients with or without type 2 diabetes in Austria and Switzerland. Journal of Medical Economics. 2023;26:1287-300.

  12. Roche. Literature review. Search No. 24-0084. Data on file.